Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Fraietta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|March 15, 2016
The development of high-content screening (HCS) technology and its importance to drug discoveryIvan Fraietta, Fabio Gasparri
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2025
A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell LinesFabio Gasparri, Ivan Fraietta, Laura Gianellini, et al.
Molecular Cancer Therapeutics|September 18, 2023
Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical StudiesBarbara Valsasina, Paolo Orsini, Michele Caruso, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted ConjugateAndré Raposo Moreira Dias, Arianna Pina, Amelia Dean, et al.
Plos One|October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing CompoundsMarta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Oncotarget|October 3, 2015
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningMaria Anania, Fabio Gasparri, Elena Cetti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Tumor Targeting with an isoDGR-Drug ConjugateSimone Zanella, Simona Angerani, Arianna Pina, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|March 15, 2016
The development of high-content screening (HCS) technology and its importance to drug discoveryIvan Fraietta, Fabio Gasparri
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2025
A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell LinesFabio Gasparri, Ivan Fraietta, Laura Gianellini, et al.
Molecular Cancer Therapeutics|September 18, 2023
Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical StudiesBarbara Valsasina, Paolo Orsini, Michele Caruso, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted ConjugateAndré Raposo Moreira Dias, Arianna Pina, Amelia Dean, et al.
Plos One|October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing CompoundsMarta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Oncotarget|October 3, 2015
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningMaria Anania, Fabio Gasparri, Elena Cetti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Tumor Targeting with an isoDGR-Drug ConjugateSimone Zanella, Simona Angerani, Arianna Pina, et al.
Pageof 1